Clinical Trial Update: An Efficacy and Safety Study of DFL24498 in the Treatment of AKC [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating the efficacy and safety of DFL24498 for treating atopic keratoconjunctivitis, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Keratoconjunctivitis

Drugs mentioned

• DFL24498

Snippet

Sponsor: Dompé Farmaceutici S.p.A | Conditions: Atopic Keratoconjunctivitis | Phase 3 | Status: RECRUITING